Nurix Therapeutics, Inc. (NRIX) earnings

  • Healthcare
  • NASDAQ
  • Market cap$1.4B

Next report

2027-01-27

In 67 daysQ4 FY2026Time not announced· Expected date
EPS consensus
-0.46
-0.71 – -0.154 analysts
Revenue consensus
$288M

Latest result

40 days ago

⁦+2664.3%⁩Revenue Beat

Estimate recorded after the release

2026-10-12Q3 FY2026AMC
EPS
Reported / estimate4.73 / -0.60
Revenue
$673M / $24.3M

Stock reaction

⁦-0.14%⁩

⁦-0.12⁩ pts vs SPY

Session ⁦2026-10-13⁩

Recent quarters

Latest 2 quarters

Revenue and stock reaction

Reported / estimate

  • Q3 FY2026 · 2026-10-12-0.14%
    EPS4.73 / -0.60+887.2%†
    Revenue$673M / $24.3M+2664.3%
  • Q2 FY2026 · 2026-07-09-6.60%
    EPS-0.81 / -0.72-12.0%
    Revenue$9.04M / $15.3M-40.9%
  • †Unusually large: likely a one-off gain or charge, so not comparable with consensus
  • Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.